Literature DB >> 32448783

Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis.

Sara Monti1, Paolo Delvino2, Elisa Bellis2, Alessandra Milanesi2, Fabio Brandolino2, Carlomaurizio Montecucco2.   

Abstract

Entities:  

Keywords:  giant cell arteritis; glucocorticoids; systemic vasculitis

Mesh：

Year:  2020        PMID： 32448783     DOI： 10.1136/annrheumdis-2020-217915

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.

Authors:  Vincent Issac Lau; Sumeet Dhanoa; Harleen Cheema; Kimberley Lewis; Patrick Geeraert; David Lu; Benjamin Merrick; Aaron Vander Leek; Meghan Sebastianski; Brittany Kula; Dipayan Chaudhuri; Arnav Agarwal; Daniel J Niven; Kirsten M Fiest; Henry T Stelfox; Danny J Zuege; Oleksa G Rewa; Sean M Bagshaw
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19.

Authors:  Rosamond Luther; Sarah Skeoch; John D Pauling; Christopher Curd; Felicity Woodgate; Sarah Tansley
Journal:  Rheumatol Adv Pract       Date:  2020-12-01

3.  What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern.

Authors:  Philipp Gauckler; Erica L Bettac; Manfred Nairz; Christina Duftner; Anna K Luger; Markus Stein; David Wanner; Barbara C Böckle; Martin Tiefenthaler; Peter Schratzberger; Hannes Neuwirt; Lukas Harasser; Gert Mayer; Andreas Kronbichler
Journal:  Ann Rheum Dis       Date:  2020-12-01       Impact factor: 19.103

Review 4.  Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective.

Authors:  Sarah L Mackie; Elisabeth Brouwer; Richard Conway; Kornelis S M van der Geest; Puja Mehta; Susan P Mollan; Lorna Neill; Michael Putman; Philip C Robinson; Sebastian E Sattui
Journal:  Lancet Rheumatol       Date:  2020-12-08

5.  Arteritic Anterior Ischemic Optic Neuropathy in the Course of Giant Cell Arteritis After COVID-19.

Authors:  Urszula Szydełko-Paśko; Joanna Przeździecka-Dołyk; Julia Kręcicka; Rafał Małecki; Marta Misiuk-Hojło; Anna Turno-Kręcicka
Journal:  Am J Case Rep       Date:  2022-01-11

6.  A Case Report of Post COVID19 Giant Cell Arteritis and Polymyalgia Rheumatica With Visual Loss.

Authors:  Ali M Mursi; Hyder O Mirghani; Adel A Elbeialy
Journal:  Clin Med Insights Case Rep       Date:  2022-03-21

7.  Where Have All the FLOWERS Gone? A Multicenter Investigation of Frequent Users of Midwest Emergency Department Services During the COVID-19 Stay-at-home Orders.

Authors:  Howard W Levitin; Bruce G Jones; Marie M Lockhart; Christopher M Lloyd; Meenal D Sharkey; Paul A Willette; Andrew F Kalnow
Journal:  West J Emerg Med       Date:  2022-09-15

8.  Isolated popliteal artery lesion due to giant cell vasculitis post COVID-19 mRNA vaccine and COVID-19 asymptomatic infection.

Authors:  Roberto Gabrielli; Andrea Siani; Gianluca Smedile; Anna Rita Rizzo; Gennaro De Vivo; Federico Accrocca; Stefano Bartoli
Journal:  Vascular       Date:  2022-10-06       Impact factor: 1.105

9.  Telemedicine in rheumatology: a reliable approach beyond the pandemic.

Authors:  Lorenzo Cavagna; Giovanni Zanframundo; Veronica Codullo; Maria Grazia Pisu; Roberto Caporali; Carlomaurizio Montecucco
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

Review 10.  Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.

Authors:  B Hellmich; A F Águeda; S Monti; R Luqmani
Journal:  Curr Rheumatol Rep       Date:  2020-10-12       Impact factor: 4.592
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.